Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/193966
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMuñoz-Torrero López-Ibarra, Diego-
dc.contributor.authorSchopfer, Lawrence M.-
dc.contributor.authorLockridge, Oksana-
dc.date.accessioned2023-02-22T11:55:29Z-
dc.date.available2023-02-22T11:55:29Z-
dc.date.issued2023-
dc.identifier.issn0893-228X-
dc.identifier.urihttp://hdl.handle.net/2445/193966-
dc.description.abstractChronic low-dose exposure to organophosphorus (OP) toxicants is correlated with an increase in the risk of impaired cognition and neurodegenerative diseases. A mechanism to explain this relationship is needed. We suggest that the formation of organophosphate-induced high-molecular-weight protein aggregates that disrupt cell function may be the missing link. It has been demonstrated that such aggregation can be promoted by OP-labeled lysine. Alternatively, OP-labeled glutamate may be the initiator. To test this hypothesis, we treated MAP-rich tubulin Sus scrofa and human transglutaminase with chlorpyrifos oxon. Trypsin-digested proteins were subjected to liquid chromatography−tandem mass spectrometry followed by Protein Prospector searches to identify diethyl phosphate adducts and cross-linked peptides. We report the presence of diethyl phosphate adducts on the side chains of glutamate, lysine, and tyrosine, as well as cross-links between glutamate and lysine. Glutamate-lysine cross-linking could be initiated either by diethyl phosphate-activated glutamate or by diethyl phosphate-activated lysine to form stable isopeptide bonds between and within proteins. It was concluded that organophosphate-induced high-molecular-weight protein aggregates could promote brain dysfunction.-
dc.format.extent10 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherAmerican Chemical Society-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1021/acs.chemrestox.2c00333-
dc.relation.ispartofChemical Research in Toxicology, 2023, vol. 36, num. 1, p. 112-121-
dc.relation.urihttps://doi.org/10.1021/acs.chemrestox.2c00333-
dc.rightscc by-nc-nd (c) Diego Muñoz-Torrero López-Ibarra, et al., 2023-
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.sourceArticles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)-
dc.subject.classificationMalalties neurodegeneratives-
dc.subject.classificationPèptids-
dc.subject.classificationProteïnes-
dc.subject.classificationÀcids nucleics-
dc.subject.otherNeurodegenerative Diseases-
dc.subject.otherPeptides-
dc.subject.otherProteins-
dc.subject.otherNucleic acids-
dc.titleChlorpyrifos oxon activates glutamate and lysine for protein cross-linking-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec728358-
dc.date.updated2023-02-22T11:55:29Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)

Files in This Item:
File Description SizeFormat 
728358.pdf4.23 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons